Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 10930012310012 | Other Grant/Funding Number | ZonMw |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Amsterdam UMC, location VUmc | OTHER |
| InHolland University of Applied Sciences | OTHER |
Not provided
Not provided
Not provided
Lifestyle Intervention in the memory clinics of General and academic Hospitals Trial (LIGHT) is a multi-center, randomized, controlled, lifestyle intervention trial among 300 older adults (≥50 years) with subjective cognitive decline (SCD) and mild cognitive impairment (MCI) at risk of dementia. Participants are randomized in a 1:1 ratio to Group A (tailored lifestyle intervention) or Group B (general health advice) for a duration of 12 months. The lifestyle intervention comprises three parts 1) Lifestyle coaching, 2) a voucher program, and 3) online self-management. Group B will receive general health advice.
Rationale: Dementia prevention through lifestyle has much potential but is not implemented in routine care. Patients referred to memory clinics, such as people with mild cognitive impairment (MCI) and subjective cognitive disorder (SCD), are at high risk for dementia and tend to have a worse health and lifestyle profile. While they might greatly benefit from lifestyle changes, there is no offer to help them make those changes.
Objective: The primary objectives are to examine both the (cost-)effectiveness of an innovative 1-year lifestyle intervention on lifestyle change measured by the validated Lifestyle for Brain Health Score (LIBRA) in older adults with SCD or MCI; and to identify possibilities, barriers, and facilitators for sustainable implementation of the lifestyle intervention.
Study design: Multicenter, randomized controlled trial comparing a lifestyle intervention with care as usual and general health advice.
Study population: 300 older adults (≥50 years) with SCD and MCI at risk of dementia.
Intervention: Participants are randomly allocated on a 1:1 ratio to participate either in Group A (tailored lifestyle intervention) or Group B (general health advice) for a duration of 12 months. The lifestyle intervention comprises three parts 1) Lifestyle coaching, 2) a voucher program, and 3) online self-management. Group B will receive general health advice.
Main study parameters/endpoints: The primary outcome will be change in participants' dementia risk profile as measured by the LIBRA score between baseline and 12 months. Secondary outcomes include cognitive functions (episodic memory, executive functions, information processing speed and attention). Other secondary outcomes include measures of body mass index (height and weight), office systolic and diastolic blood pressure, and lab measures including cholesterol levels (total, HDL, LDL, triglycerides), HbA1c levels, creatinine-based eGFR levels. Smoking, alcohol intake and current relevant medical conditions (coronary heart disease, kidney disease, type 2 diabetes, depression, hearing loss, sleep disorders) will be assessed through self-report. Additional questionnaires include health-related quality of life and capabilities, instrumental activities of daily living, health locus of control, self-efficacy, mastery, healthy diet, physical activity, cognitive stimulation, stress, and depressive symptoms, sleep quality, social support and feelings of loneliness, and lastly knowledge on dementia risk and protective factors. For cost-effectiveness, questionnaires on resource utilization, medical consumption, and productivity costs are administered. Additional measures include change in diagnosis (if applicable), demographics (age, sex, educational level, socioeconomic position (household income), paid/voluntary work hours, ethnicity, marital status, living situation), medication use, hearing loss. For process evaluation, questionnaires and interviews are administered on implementation, mechanisms of impact and contact (e.g., appointments with lifestyle coach, use of the breinzorg.nl self-management tool, use of the voucher program, experiences and usefulness, etc.).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Lifestyle intervention (Group A) | Experimental | Group A receives a personalized lifestyle intervention. |
|
| Regular healthcare (Group B) | No Intervention | Group B receives regular health care and a folder with general information on lifestyle and dementia risk reduction. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Personalized lifestyle intervention | Behavioral | The lifestyle intervention in Group A comprises three parts (1) three individual consultations with a trained lifestyle coach, (2) a voucher program to encourage brain healthy activities, and (3) access to an online self-management tool for dementia risk reduction (www.breinzorg.nl). |
| Measure | Description | Time Frame |
|---|---|---|
| Lifestyle for BRAin Health (LIBRA) score 2 | 1-year change in the Lifestyle for BRAin Health (LIBRA) score 2. This is a weighted score of fifteen lifestyle-related risk factors that are proven to be associated with increased dementia risk. Higher score means a greater risk for dementia. Scored from -6.1 to 25.8 (absolute weight). | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| 15-Word Verbal Learning Test | Measure of immediate and delayed memory. Wordlist is presented five times in a row and asked to be recalled immediately and after 15 minutes. Discrete number; score: 0-15 (higher score means a better outcome) | 1 year |
| Digit Symbol Substitution Test (DSST) |
| Measure | Description | Time Frame |
|---|---|---|
| Biomarkers | Plasma samples will be stored to later assess biomarkers. For example amyloid, p-tau, NFL, GFAP, BDNF. | 1 year |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Niels Janssen, PhD | Contact | +316 14348188 | n.janssen@maastrichtuniversity.nl | |
| Veerle van Gils, PhD | Contact | +316 14348188 | v.vangils@maastrichtuniversity.nl |
| Name | Affiliation | Role |
|---|---|---|
| Sebastian Köhler, Professor | Maastricht University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Alzheimer Center Amsterdam | Recruiting | Amsterdam | Netherlands |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38872204 | Background | Deckers K, Zwan MD, Soons LM, Waterink L, Beers S, van Houdt S, Stiensma B, Kwant JZ, Wimmers SCPM, Heutz RAM, Claassen JAHR, Oosterman JM, de Heus RAA, van de Rest O, Vermeiren Y, Voshaar RCO, Smidt N, Broersen LM, Sikkes SAM, Aarts E; MOCIA consortium; FINGER-NL consortium; Kohler S, van der Flier WM. A multidomain lifestyle intervention to maintain optimal cognitive functioning in Dutch older adults-study design and baseline characteristics of the FINGER-NL randomized controlled trial. Alzheimers Res Ther. 2024 Jun 13;16(1):126. doi: 10.1186/s13195-024-01495-8. | |
| 38159267 |
| Label | URL |
|---|---|
| ZonMw description | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D040242 | Risk Reduction Behavior |
| D060825 | Cognitive Dysfunction |
| D003704 | Dementia |
| ID | Term |
|---|---|
| D001519 | Behavior |
| D003072 | Cognition Disorders |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Group A receives a personalised lifestyle intervention. Group B will receive general information on lifestyle in relation to dementia risk reduction.
Not provided
Not provided
Not provided
|
Measure of attention/processing speed, number of correctly matched symbols to digits within 90 seconds. Discrete number; 0-90 (higher score means a better outcome). |
| 1 year |
| Wechsler Adult Intelligent Scale (WAIS) digit span | Measure of working memory. Scored as the maximum number of digits repeated correctly. Discrete number; 0-14 (higher score means a better outcome). | 1 year |
| Trail Making Test | Measure of attention and executive function. Task A and B. Time taken to complete the test; minimum 0, no maximum, lower score means a better outcome. | 1 year |
| Semantic Fluency Test | Measure of language fluency. Semantic fluency test with category animals at baseline and professions at follow-up. Word count in one minute; minimum 0, no maximum, higher score means a better outcome. | 1 year |
| EuroQol-5D-5L | Quality of life, score 0-100, higher scores indicate better quality of life | 1 year |
| ICEpop CAPability measure for Older people (ICECAP-O) | Capabilities, score 0-1, higher scores indicate greater capabilities. | 1 year |
| Health locus of Control Scale | 3 subscales, where each subscale ranges from 6 (minimum score) to 36 (maximum score). Higher scores indicate higher health locus of control. | 1 year |
| General Self-Efficacy scale | Total score ranges from 10 (minimum score) to 40 (maximum score), with higher scores representing higher self-efficacy. | 1 year |
| Pearlin Mastery Scale | Total score ranges from 7 (minimum score) to 28 (maximum score), where higher scores indicate greater levels of mastery. | 1 year |
| Cholesterol | Total, HDL, LDL and triglycerides in plasma (mmol/L). | 1 year |
| Hemoglobin A1c | Hemoglobin A1C (HbA1c) measured in plasma (%), indicates plasma glucose as a measure for diabetes status | 1 year |
| Estimated glomerular filtration rate (eGFR) | Creatinine-based (as measured in plasma) estimated glomerular filtration rate (eGFR) (healthy level: higher than 60) indicating kidney function. | 1 year |
| Body mass Index (BMI) | As calculated from weight (kg) and height (m), weight / height ^2 | 1 year |
| Blood pressure | Scores range from approximately (for diastolic) 60-120 and (for systolic) 100-180 mmHg, with higher measures indicating higher blood pressure. | 1 year |
| Medical history | History of diabetes, coronary heart disease, kidney disease, hypertension, dyslipidemia, depression, hearing loss, poor vision, sleep disorders (asked in interview) | 1 year |
| Amsterdam-Instrumental Activities Daily Living (ADL) Questionnaire | Total scores range approximately 20-70, higher scores indicate better ADL functioning. | 1 year |
| Mediterranean Diet Adherence Screener (MEDAS) | Total score ranges from 0 (minimum score) to 14 (maximum score), with higher scores indicating higher adherence to Mediterranean diet. | 1 year |
| Investigation into Cancer and Nutrition (EPIC) physical activity questionnaire | Physical activity, uses Cambridge Physical Activity Index to categorize into 4 levels based on occupational and leisure-time activities. | 1 year |
| Cognitive and Leisure Activities Scale | The score ranges from 0 (minimum score) to 45 (maximum score), with higher scores representing higher cognitive and leisure activities. | 1 year |
| Perceived Stress Scale | Total score, scale 0 - 40, higher scores indicate more perceived stress. | 1 year |
| Patient Health Questionnaire (PHQ)-9 | Total score ranges from 0 (minimum score) to 27 (maximum score), with higher scores representing a worse outcome (more depressive symptoms). | 1 year |
| Groningen Sleep Quality Scale (GSKS) | The score ranges from 0 (minimum score) to 14 (maximum score), with higher scores representing a worse outcome (worse sleep quality) | 1 year |
| 6-item Lubben social network Scale | The score ranges from 0 (minimum score) to 30 (maximum score), with higher scores meaning a better outcome (higher level of perceived social support) | 1 year |
| De Jong Gierveld 6-item Scale | The score ranges from 0 (minimum score) to 6 (maximum score), with higher scores representing a worse outcome (higher loneliness scores). | 1 year |
| Knowledge on dementia risk questionnaire | Measure awareness on risk and protective factors, higher score indicates better knowledge (0-25). | 1 year |
| Smoking | Duration (current/history) and quantity | 1 year |
| Alcohol intake | Measured in duration (current/history) and quantity | 1 year |
| Medical Consumption Questionnaire (iMCQ) | Medical consumption, selection of specific questions on care use such as GP visits and dietician. Used to calculate overall costs of medical care to define the cost-effectiveness of the intervention. Lower costs is a better score. | 1 year |
| Productivity Costs Questionnaire (iPCQ) | Measures productivity costs, used to calculate cost-effectiveness of the intervention. Higher productivity and lower costs is a better score. | 1 year |
| Adherence | Appointments missed, personal goals reached in coaching sessions (number), vouchers used (number), usage log of breinzorg.nl self-management tool (time active, modules completed). Together, they will be used in a model to calculate cost-effectiveness of the intervention based on the adherence. | 1 year |
| Maastricht University | Recruiting | Maastricht | Netherlands |
|
| Background |
| Rosenau C, Kohler S, Soons LM, Anstey KJ, Brayne C, Brodaty H, Engedal K, Farina FR, Ganguli M, Livingston G, Lyketsos CG, Mangialasche F, Middleton LE, Rikkert MGMO, Peters R, Sachdev PS, Scarmeas N, Salbaek G, van Boxtel MPJ, Deckers K. Umbrella review and Delphi study on modifiable factors for dementia risk reduction. Alzheimers Dement. 2024 Mar;20(3):2223-2239. doi: 10.1002/alz.13577. Epub 2023 Dec 30. |
| 41508135 | Derived | van Gils V, Waterink L, Wimmers SCPM, Jelsma JGM, de Vugt ME, Handels R, Sikkes SAM, van der Flier WM, Deckers K, Zwan MD, Kohler S, Janssen N. The Lifestyle Intervention in memory clinics of General and academic Hospitals Trial (LIGHT): Rationale and study design of a randomized controlled trial to reduce modifiable dementia risk. Alzheimers Res Ther. 2026 Jan 8;18(1):31. doi: 10.1186/s13195-025-01947-9. |
| Alzheimer Center Limburg description | View source |
| D001927 |
| Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |